SM
SMM.F Sumitomo Chemical Company Limited
- Market cap
- EUR 4.74B
- P/E
- 8.5x
- P/B
- 0.71x
- ROE
- 14.2%
- Dividend yield
- 3.54%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.
Is SMM.F undervalued?
Graham numberSMM.F trades 48.0% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sumitomo Chemical Company Limited fundamental analysis
No fundamental analysis for Sumitomo Chemical Company Limited yet.
Sumitomo Chemical Company Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sumitomo Chemical Company Limited
Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. The Agro & Life Solutions segment offers crop protection chemicals, fertilizers, agricultural materials, household insecticides, products for control of infectious diseases, and feed additives, etc. The ICT & Mobility Solutions segment provides optical products, semiconductor processing materials, compoun…
Full company profileSumitomo Chemical Company Limited financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Sumitomo Chemical Company Limited annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.95T | 2.19T | 2.32T | 2.23T | 2.29T | 2.77T | 2.90T | 2.45T | 2.61T | 2.33T | 2.35T |
| Gross Profit | 669B | 750B | 742B | 707B | 771B | 874B | 821B | 500B | 725B | 668B | 758B |
| Operating Income | 134B | 196B | 146B | 128B | 150B | 173B | -24.2B | -431B | 172B | 195B | 203B |
| EBITDA | - | 370B | 312B | 282B | 293B | 431B | 208B | -258B | 342B | 301B | 420B |
| Net Income | 85.5B | 134B | 118B | 30.9B | 46.0B | 162B | 6.99B | -312B | 38.6B | 60.9B | 166B |
| EPS | 52 | 82 | 72 | 19 | 28 | 99 | 4.27 | -191 | 24 | 37 | 101 |
| Balance Sheet | |||||||||||
| Total Assets | 2.86T | 3.07T | 3.17T | 3.65T | 3.99T | 4.31T | 4.17T | 3.93T | 3.44T | 3.41T | 3.63T |
| Total Liabilities | 1.70T | 1.82T | 1.82T | 2.26T | 2.51T | 2.61T | 2.68T | 2.77T | 2.37T | 2.17T | 2.14T |
| Shareholders' Equity | 820B | 927B | 999B | 922B | 1.02T | 1.22T | 1.17T | 966B | 901B | 1.01T | 1.17T |
| Cash & Short-term Investments | 161B | 232B | 202B | 181B | 361B | 365B | 306B | 217B | 210B | 209B | 208B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 187B | 293B | 208B | 106B | 374B | 172B | 112B | -51.3B | 233B | 235B | 133B |
| Capital Expenditure | 132B | 149B | 175B | 120B | 121B | 107B | 144B | 153B | 130B | 122B | 71.8B |
| Free Cash Flow | - | 293B | 208B | 106B | 374B | 172B | 112B | -204B | 103B | 113B | 133B |
| Ratios | |||||||||||
| ROE | 10.4% | 14.4% | 11.8% | 3.4% | 4.5% | 13.3% | 0.6% | -32.3% | 4.3% | 6.0% | 14.2% |
| ROA | 3.0% | 4.4% | 3.7% | 0.8% | 1.2% | 3.8% | 0.2% | -7.9% | 1.1% | 1.8% | 4.6% |
| Net Profit Margin | 4.4% | 6.1% | 5.1% | 1.4% | 2.0% | 5.9% | 0.2% | -12.7% | 1.5% | 2.6% | 7.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Sumitomo Chemical Company Limited dividends
- Dividend yield
- 3.54%
- Forward dividend
- 0.10 EUR
- Payout ratio
- 32.3%
- Ex-dividend date
- Mar 30, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 19.7B | 12 | 32.3% |
| 2025 | JPY 9.87B | 6.03 | 25.6% |
| 2024 | JPY 19.6B | 12 | - |
| 2023 | JPY 42.5B | 26 | 608.0% |
| 2022 | JPY 31.1B | 19 | 19.2% |
| 2021 | JPY 19.6B | 12 | 42.6% |
| 2020 | EUR 36.0B | 22 | 116.3% |
| 2019 | EUR 37.6B | 23 | 31.9% |
| 2018 | EUR 27.8B | 17 | 20.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Sumitomo Chemical Company Limited
- Insiders 2.60%
- Institutions 41.84%
- Public & others 55.55%
- Shares outstanding 1.63B
- Free float 1.63B
Sumitomo Chemical Company Limited company profile
- Company name
- Sumitomo Chemical Company Limited
- Ticker
- SMM.F
- ISIN
- JP3401400001
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 27,491
- Fiscal year end
- March
- Address
- Tokyo Nihombashi Tower, Tokyo, Japan, 103-6020
- Phone
- 81 3 5201 0200
- Website
- sumitomo-chem.co.jp
About Sumitomo Chemical Company Limited
Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. The Agro & Life Solutions segment offers crop protection chemicals, fertilizers, agricultural materials, household insecticides, products for control of infectious diseases, and feed additives, etc. The ICT & Mobility Solutions segment provides optical products, semiconductor processing materials, compound semiconductor materials, touch screen sensor panels, high-purity aluminum and alumina, specialty chemicals, additives, engineering plastics, and battery materials, etc. The Advanced Medical Solutions segment offers contract development and manufacturing organization business for small-molecule active ingredients and intermediates, oligonucleic acid drug substances, and regenerative medicine, and cell therapy products, etc. The Essential & Green Materials segment offers synthetic resins, raw materials for synthetic fibers, various industrial chemicals, methyl methacrylate products, industrial aluminum and alumina, and synthetic rubber, etc. The Sumitomo Pharma segment offers small molecule pharmaceuticals. Additionally, the company engages in the manufacture and sale of positive electrode materials for rechargeable batteries. Sumitomo Chemical Company, Limited was founded in 1913 and is headquartered in Tokyo, Japan.
Sumitomo Chemical Company Limited management
10- Mr. Nobuaki MitoPresident, CEO & Representative Director · born 1960
- Mr. Keigo SasakiSenior Managing Executive Officer of Corporate Comm, Corp Planning, Acc & Finance and Rep Director · born 1963
- Mr. Masaki MatsuiExecutive VP & Head of ICT & Mobility Solutions Division · born 1960
- Engineer Seiji TakeuchiSr Managing Ex Officer, Head of Essential & Green Materials Sec, Bus Dev for Circular Carbon Eco · born 1962
- Mr. Takanari YamaguchiDirector & Senior Managing Executive Officer · born 1962
- Mr. Megumi SakuramotoChief ESG Analyst
- Koichi OginoSMEO of Prod. Tech., Prod. Safety Infr. Cen., Eng, Resp. Care, Purchasing, Logi. Mgmt
- Mr. Juan FerreiraManaging Executive Officer
- Mr. Toshihiro YamauchiManaging Executive Officer
- Akira NakanishiManaging Executive Officer